MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-09-0002858
Asolear Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.69 Lakh
▲ 49% YoY
Net loss · FY 2024
₹81,130
Net margin -30.1%
EBITDA · FY 2024
₹16,398
EBITDA margin 6.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Asolear Pharma Private Limited
Data last updated:
Asolear Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24297DL2013PTC251451. Its GSTIN is 07AALCA5835F1ZM (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Kumar Kushwaha and Sudhir Kumar Kushwaha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 133 Sheds Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.69 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net loss of ₹81,130 (net margin -30.1%) and EBITDA of ₹16,398 (EBITDA margin 6.1%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 39% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Asolear Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0002858). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asolearpharma.co.in.
Company details
CIN U24297DL2013PTC251451
Registration Number 251451
Incorporation Date 02 May 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-09-0002858
Recognitions & Rankings of Asolear Pharma
Contact details
Asolear Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is asolearpharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 133 Sheds Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Asolear Pharma Private Limited, buy the company report.
Comprehensive company report
Asolear Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Asolear Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Asolear Pharma Private Limited, buy the company report.
Financials of Asolear Pharma Private Limited
FY 2025 filings availableAsolear Pharma Private Limited reported revenue of ₹2.69 Lakh (up 49% YoY) for FY 2024.
Revenue · FY 2024
₹2.69 Lakh ▲ 49%
Net loss · FY 2024
₹81,130 margin -30.1%
EBITDA · FY 2024
₹16,398 margin 6.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 49%
3 years · compounded
▼ 46%
5 years · compounded
▼ 39%
EBITDA CAGR growth
1 year
▲ 107%
3 years · compounded
▼ 56%
5 years · compounded
▼ 36%
Revenue rose 49% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 39%. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16,398 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹81,130 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | ||||
| Net Profit Margin | -30.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Asolear Pharma Private Limited, buy the company report.
Board of directors of Asolear Pharma Private Limited
Asolear Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar Kushwaha Also directs: Asolear Aesthetics Private Limited | Director | 02 May 2013 | 13 Years 5 Months | Current |
| Sudhir Kumar Kushwaha Also directs: Asolear Aesthetics Private Limited | Director | 18 Aug 2022 | 4 Years 2 Months | Current |
Auditor
Asolear Pharma Private Limited is audited by NAGARIA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAGARIA & ASSOCIATES | FY 2019 | 023227N |
Shareholding
The shareholding of Asolear Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Asolear Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 May 2021 | 100446352 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Asolear Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Asolear Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Asolear Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCA5835F1ZM | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Asolear Pharma Private Limited, buy the company report.
Recent activity
Asolear Pharma Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Rajender Saini ceased to be Director on 13 Feb 2024.
AGM
Asolear Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Asolear Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Rajender Saini ceased to be Director.
Appointed
Sudhir Kumar Kushwaha was appointed as Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100446352 was registered on 01 May 2021.
Ceased
Dinesh Mittal ceased to be Director.
Ceased
Bhavna Agarwal ceased to be Director.
Appointed
Sandeep Kumar Kushwaha was appointed as Director.
Incorporation
02 May 2013
Asolear Pharma Private Limited was registered on 02 May 2013 with Roc Delhi I & aged 13 years 5 months as per MCA records.
Frequently asked questions
Asolear Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 May 2013 (13+ years old) and is registered under CIN U24297DL2013PTC251451.
Asolear Pharma has 2 current directors:
- Sandeep Kumar Kushwaha - Director
- Sudhir Kumar Kushwaha - Director
The latest financial statements of Asolear Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Asolear Pharma is 07AALCA5835F1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Asolear Pharma is U24297DL2013PTC251451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Asolear Pharma was incorporated on 02 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Rajender Saini ceased to be Director on 13 Feb 2024. Sudhir Kumar Kushwaha was appointed as Director on 18 Aug 2022. Dinesh Mittal ceased to be Director on 14 Jan 2017. Asolear Pharma has 5 board changes on record in total.
Yes, Asolear Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-09-0002858).
Asolear Pharma can be reached through the website asolearpharma.co.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Asolear Pharma is at B – 133 Sheds Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.